About the Authors

Tsuyoshi Mikkaichi

Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Software, Visualization, Writing – original draft, Writing – review & editing

tsuyoshimikkaichi@gmail.com (TM); ahoffmann@ucla.edu (AH)

Affiliations Institute for Quantitative and Computational Biosciences, University of California, Los Angeles, California, United States of America, Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, California, United States of America

Michael R. Yeaman

Roles Funding acquisition, Supervision, Writing – review & editing

Affiliations David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America, Divisions of Molecular Medicine and Infectious Diseases, Harbor-UCLA Medical Center, Torrance, California, United States of America, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, United States of America

Alexander Hoffmann

Roles Funding acquisition, Project administration, Supervision, Writing – original draft, Writing – review & editing

tsuyoshimikkaichi@gmail.com (TM); ahoffmann@ucla.edu (AH)

Affiliations Institute for Quantitative and Computational Biosciences, University of California, Los Angeles, California, United States of America, Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, California, United States of America, David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America

MRSA Systems Immunobiology Group

Membership list of the MRSA Systems Immunobiology Group can be found in the Acknowledgments section.

Competing Interests

MRY is founder and shareholder of NovaDigm Therapeutics, Inc. which develops vaccines and immunotherapeutics for infections, including Staphylococcus aureus.